Metraipolis › archive › dc_f2e8737fa22c

Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer — Europe PMC PMID:41596365

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41596365
DOI
10.3390/ijms27020713
License (as archived)
solo-consultazione
Archived
2026-11-06T22:20:34.409Z
SHA-256 of the archived text
7d8524dc6b5531e08e0467a64caedc722c5e6f63202ffc28e44e14a970afba78
Stable URL of this page
https://metraipolis.com/documento/dc_f2e8737fa22c

How to cite

Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer — Europe PMC PMID:41596365 — Europe PMC (en), https://europepmc.org/article/MED/41596365 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f2e8737fa22c (Metraipolis archive dc_f2e8737fa22c, sha256 7d8524dc6b5531e08e0467a64caedc722c5e6f63202ffc28e44e14a970afba78)
BibTeX
@misc{dcf2e8737fa22c,
  title = {Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer — Europe PMC PMID:41596365},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41596365},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f2e8737fa22c; sha256 7d8524dc6b5531e08e0467a64caedc722c5e6f63202ffc28e44e14a970afba78},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41596365. Agents can read the archived copy with the MCP tool read_document.